Graduate School of Ningxia Medical University, Yinchuan, Ningxia, China.
Department of Orthopedics,People's Hospital of Ningxia Hui Autonomous Region, No. 56, Zhengyuan Street, Yinchuan, 750002, Ningxia, China.
BMC Musculoskelet Disord. 2021 Nov 16;22(1):957. doi: 10.1186/s12891-021-04845-x.
New vertebral compression fractures (NVCFs) are adverse events after vertebral augmentation of osteoporotic vertebral compression fractures (OVCFs). Predicting the risk of vertebral compression fractures (VCFs) accurately after surgery is still a significant challenge for spinal surgeons. The aim of our study was to identify risk factors of NCVFs after vertebral augmentation of OVCFs and develop a nomogram.
We retrospectively reviewed the medical records of patients with OVCFs who underwent percutaneous vertebroplasty (PVP) or percutaneous kyphoplasty (PKP). Patients were divided into the NVCFs group and control group, base on the patients with or without NVCFs within 2 years follow-up period after surgery. A training cohort of 403 patients diagnosed in our hospital from June 2014 to December 2016 was used for model development. The independent predictive factors of postoperative VCFs were determined by least absolute shrinkage and selection operator (LASSO) logistic regression, univariate analysis and multivariate logistic regression analysis. We provided a nomogram for predicting the risk of NVCFs based on independent predictive factors and used the receiver operating characteristic curve (ROC), calibration curve, and decision curve analyses (DCA) to evaluated the prognostic performance. After internal validation, the nomogram was further evaluated in a validation cohort of 159 patients included between January 2017 and June 2018.
Of the 403 patients in the training cohort, 49(12.16%) were NVCFs at an average of 16.7 (1 to 23) months within the 2 years follow-up period. Of the 159 patients in the validation cohort, 17(10.69%) were NVCFs at an average of 8.7 (1 to 15) months within the 2 years follow-up period. In the training cohort, the proportions of elderly patients older than 80 years were 32.65 and 13.56% in the NVCFs and control group, respectively (p = 0.003). The percentages of patients with previous fracture history were 26.53 and 12.71% in the NVCFs and control group, respectively (p = 0.010). The volume of bone cement were 4.43 ± 0.88 mL and 4.02 ± 1.13 mL in the NVCFs and Control group, respectively (p = 0.014). The differences have statistical significance in the bone cement leakage, bone cement dispersion, contact with endplate, anti-osteoporotic treatment, post-op Cobb angle and Cobb angle restoration characteristics between the two groups. The model was established by multivariate logistic regression analysis to obtain independent predictors. In the training and validation cohort, the AUC of the nomogram were 0.882 (95% confidence interval (CI), 0.824-0.940) and 0.869 (95% CI: 0.811-0.927), respectively. The C index of the nomogram was 0.886 in the training cohort and 0.893 in the validation cohort, demonstrating good discrimination. In the training and validation cohort, the optimal calibration curves demonstrated the coincidence between prediction and actual status, and the decision curve analysis demonstrated that the full model had the highest clinical net benefit across the entire range of threshold probabilities.
A nomogram for predicting NVCFs after vertebral augmentation was established and validated. For patients evaluated by this model with predictive high risk of developing postoperative VCFs, postoperative management strategies such as enhance osteoporosis-related health education and management should be considered.
新的椎体压缩性骨折(NVCFs)是骨质疏松性椎体压缩性骨折(OVCFs)椎体增强术后的不良事件。准确预测术后椎体压缩性骨折(VCFs)的风险仍然是脊柱外科医生面临的重大挑战。我们的研究旨在确定 OVCF 椎体增强术后 NVCFs 的风险因素,并制定一个列线图。
我们回顾性分析了 2014 年 6 月至 2016 年 12 月在我院接受经皮椎体成形术(PVP)或经皮椎体后凸成形术(PKP)治疗的 OVCF 患者的病历。根据术后 2 年内是否发生 NVCFs,将患者分为 NVCFs 组和对照组。采用最小绝对收缩和选择算子(LASSO)逻辑回归、单因素分析和多因素逻辑回归分析确定术后 VCFs 的独立预测因素。我们基于独立预测因素建立了预测 NVCFs 风险的列线图,并使用接受者操作特征曲线(ROC)、校准曲线和决策曲线分析(DCA)评估预测性能。内部验证后,该列线图在包含 2017 年 1 月至 2018 年 6 月间的 159 例患者的验证队列中进一步进行评估。
在 403 例训练队列患者中,49 例(12.16%)在术后 2 年内平均 16.7 个月(1 至 23 个月)内发生 NVCFs。在 159 例验证队列患者中,17 例(10.69%)在术后 2 年内平均 8.7 个月(1 至 15 个月)内发生 NVCFs。在训练队列中,80 岁以上老年患者的比例分别为 NVCFs 组和对照组的 32.65%和 13.56%(p=0.003)。有既往骨折史的患者比例分别为 NVCFs 组和对照组的 26.53%和 12.71%(p=0.010)。骨水泥的体积分别为 NVCFs 组和对照组的 4.43±0.88mL 和 4.02±1.13mL(p=0.014)。两组之间骨水泥渗漏、骨水泥弥散、与终板接触、抗骨质疏松治疗、术后 Cobb 角和 Cobb 角恢复特征均有统计学差异。通过多因素逻辑回归分析建立了模型,以获得独立预测因子。在训练和验证队列中,列线图的 AUC 分别为 0.882(95%置信区间(CI):0.824-0.940)和 0.869(95%CI:0.811-0.927)。列线图的 C 指数在训练队列中为 0.886,在验证队列中为 0.893,具有良好的区分度。在训练和验证队列中,最优校准曲线显示了预测与实际情况之间的一致性,决策曲线分析表明全模型在整个阈值概率范围内具有最高的临床净效益。
建立并验证了预测椎体增强术后 NVCFs 的列线图。对于通过该模型评估具有术后 VCFs 高风险的患者,应考虑增强与骨质疏松相关的健康教育和管理等术后管理策略。